Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC vs MM-AT for Knee Osteoarthritis
NCT06040957Recruiting
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Jan 2024
- Primary completion
- Jan 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised trial in knee osteoarthritis (OA) comparing BMAC Arm with MM-AT Arm (2 arms). Primary endpoint: Western Ontario and McMaster University Osteoarthritis index - Pain subscale at 6 months. Started Jan 2024; status: recruiting.
02
Drugs
autologous bone marrow cell concentrateminimally manipulated adipose tissue
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06040957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040957.